NASDAQ:LIFE
aTyr Pharma Stock News
$1.60
+0.0100 (+0.629%)
At Close: May 02, 2024
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial Results
12:01pm, Thursday, 06'th Aug 2020
Management to host conference call and webcast on August 13th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engag
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:30pm, Wednesday, 05'th Aug 2020
Atyr Pharma (LIFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Offer Insights on Healthcare Companies: Karuna Therapeutics (NASDAQ: KRTX) and aTyr Pharma (NASDAQ: LIFE) - Markets
10:21am, Wednesday, 24'th Jun 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Karuna Therapeutics (KRTX – Research
Edited Transcript of LIFE earnings conference call or presentation 12-May-20 9:00pm GMT
08:52pm, Monday, 22'nd Jun 2020
Q1 2020 aTyr Pharma Inc Earnings Call
SAN DIEGO, June 22, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathway
aTyr Pharma Inc (NASDAQ:LIFE) Expected to Post Quarterly Sales of $400,000.00
02:32am, Sunday, 21'st Jun 2020
Analysts expect aTyr Pharma Inc (NASDAQ:LIFE) to post sales of $400,000.00 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for aTyr Pharma’s ear
Stocks To Watch: Nike, Apple, Ford And Stressed Banks
08:39am, Saturday, 20'th Jun 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection
09:01pm, Wednesday, 17'th Jun 2020
Discovery that Neuropilin b1 domain acts as a binding site for SARS-CoV-2 Spike protein and aids viral entry. Lead therapeutic candidate, ATYR1923, modulates Neuropilin pathway to dampen inflammatory
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection
12:00am, Wednesday, 17'th Jun 2020
Discovery that Neuropilin b1 domain acts as a binding site for SARS-CoV-2 Spike protein and aids viral entry. Lead therapeutic candidate, ATYR1923,...
SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathway
Atyr Pharma (LIFE) Upgraded to Buy: Here's What You Should Know
04:00pm, Friday, 12'th Jun 2020
Atyr Pharma (LIFE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Buy aTyr Pharma Inc. (LIFE)?
02:43pm, Friday, 12'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Edited Transcript of LIFE earnings conference call or presentation 26-Mar-20 9:00pm GMT
09:27am, Tuesday, 02'nd Jun 2020
Q4 2019 aTyr Pharma Inc Earnings Call
aTyr Pharma to Present Poster at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
12:03pm, Wednesday, 20'th May 2020
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways